期刊文献+

核心结合因子和Ⅱ型胶原在高磷诱导的残肾大鼠血管钙化中的表达 被引量:3

Expression of core-binding factor and collagen type 2 in hyperphosphatemia-induced vascular calcification in rats with remnant kidneys
原文传递
导出
摘要 目的观察核心结合因子(Cbfα1)和Ⅱ型胶原在高磷诱导的残肾大鼠血管钙化中的表达,探讨慢性肾脏病5期血管钙化发生的可能机制。方法 40只SD雄性大鼠随即分为4组:残肾+高磷组(n=10),残肾+正常磷组(n=10),假手术+正常磷组(n=10),假手术+高磷组(n=10)。分别行5/6肾切除或假手术,术后开始给予高磷饮食或正常磷饮食16周。收集尿量检测24h尿蛋白,取血检测血清磷、肌酐、尿素氮,取胸主动组织,von kossa染色检测血管钙化,RT-PCR检测Cbfα1和Ⅱ型胶原mRNA表达,免疫组化或Western-Blot检测Cbfα1和Ⅱ型胶原蛋白表达。结果与其他3组比较,残肾+高磷组大鼠尿蛋白、血磷、尿素氮和肌酐明显增高(P<0.05)。von kossa染色显示,残肾+高磷组大鼠主动脉呈现明显钙化,而残肾+正常磷组仅个别出现钙化,假手术+高磷组和假手术+正常磷组未见钙化。免疫组化显示,与其他3组比较,残肾+高磷组大鼠主动脉Cbfα1、Ⅱ型胶原的表达明显增多(P<0.05)。相关性分析表明,血磷水平与Cbfα1、Ⅱ型胶原阳性积分呈正相关(r=0.525,0.640,P<0.05)。RT-PCR和Western-Blot显示,与其他3组比较,残肾+高磷组主动脉Cbfα1mRNA和蛋白的表达明显上调(P<0.05)。残肾+高磷组、残肾+正常磷组与另外2组相比,动脉Ⅱ型胶原mRNA表达明显上调(P<0.05)。结论高血磷是残肾大鼠血管钙化的重要影响因素,血磷水平与Cbfα1和Ⅱ型胶原的表达呈正相关。Cbfα1、Ⅱ型胶原的表达增多可能是高磷诱导的残肾大鼠血管钙化的重要机制之一。 Objective To observe the expression of core-binding factor (Cbfa) and collagen type 2(ColⅡ) in hyperphosphatemia-induced vascular calcification in rats with remnant kidneys, and to explore the possible mechanisms of vascular calcification of chronic renal disease (CKD) stage 5. Methods Forty sprague dawley rats were divided into 4 groups as follows: remnant kidney models receiving high phosphorous (HP) diet (n= 10); remnant kidney models receiving normal phosphorous (NP) diet (n= 10); sham operation models receiving NP diet (n= 10); sham operation models receiving HP diet (n= 10). After 5/6 nephrectomy or sham operation, the rats were fed with HP diet Ediet formula: phosphate (P} 1.2%, calcium (Ca) 1.6%] or NP diet [diet formula: P (0.9%), Ca (1.2%] for 16 weeks respectively. At the 16th week, urine samples were collected for 24 h urine protein, bloods were collected for serum phosphorus, serum creatinine (Scr), and urea nitrogen (UN), and thoracic aorta was removed. Calcification was confirmed by von kossa staining. Cbfa and Col Ⅱ mRNA expressions were determined by RT-PCR, and Cbfal and Col II protein expressions were determined By immunohistochemistry or Western blot. Results After16 weeks, urine protein, serum phosphorus, urea nitrogen, and creatinine levels were significantly higher in remnant kidney models receiving HP diet than those of the other three groups (P〈0.05). Von kossa staining showed that significant vascular calcification was found in remnant kidney models receiving HP diet while the remnant kidney ones receiving NP diet and sham operation models receiving HP diet occasionally had vascular calcification, and sham operation models receiving NP diet had no vascular calcification. The expression of Cbfa and Col increased significantly in remnant kidney models receiving HP diet, compared with the other three groups (P〈0.05). Serum phosphorus was positively correlated with Cbfal and Col Ⅱ staining scores (r=0. 525, 0. 640, P〈 0.05, respectively). RT-PCR and Western-Blot showed the expressions of Cbfal mRNA increased significantly in remnant kidney modeiss receiving HP diet compared with the other three groups (P〈0.05), whiie the expression of Colli mRNA increased significantly in remnant kidney models receiving HP and NP diet compared with the other two groups (P〈0.05}. Conclusion Hyperphosphatemia is an important influencing factor of vascular calcification in rats with remnant kidneys, and serum phosphorus level is positively correlated with Cbfi, and Col Ⅱexpressions. The increase of Cbfal and Col Ⅱ expressions may be one of the important mechanisms of hyperphosphatemia-indeced vascular calcification in rats with remnant kidneys.
作者 余毅 曹翠云
出处 《中华高血压杂志》 CAS CSCD 北大核心 2012年第9期847-851,共5页 Chinese Journal of Hypertension
基金 福建省科技计划重点项目(2009Y0040)
关键词 高血磷 残肾大鼠 核心结合因子 Ⅱ型胶原 血管钙化 Hyperphosphatemia Rats with remnant kidneys Core-binding factor Collagen type 2 Vascu-lar calcification
  • 相关文献

参考文献13

  • 1Schiffrin El., l.ipman ML, Mann JF. Chronic kidney disease: effects on the cardiovascular system[J]. Circulation,2007,1 16(1) :85-97.
  • 2Moe SM, (.7hen NX. Mechanisms of vascular calcification in chro nic kidney disease[J]. J Am Soc Nephrol,2008,19(2) :213-216.
  • 3Noori N, Kalantar-Zadeh K, Kovesdy CP, et al. Association of dietary phosphorus intake and phosphorus to protein ratio with mortality in hemodialysis patients[J]. Clin J Am Soc Nephrol, 2010,5(4) :683-692.
  • 4Mizobuchi M, Ogala H, Hatamura 1, el al. Up-regulation of Ch faJ and Pit-1 in calcified artery of uraemic rats with severe hyper phosphataemia and secondary hyperparathyroidism[J]. Nephrol Dial Transplant, 2006,21 (4) :911-916.
  • 5Hruska KA, Mathew S. Lund RJ, et al. The pathogenesis of vascular calcification in the chronic- kidney disease mineral hone disorder: the links between bone and the vasculature[J]. Semin NephroI,2009,29(2) :156-165.
  • 6Giaehelli CM. The emerging role of phosphate in vascular calcifi cation[J]. Kidney Int, 2009,75 (9) : 890-897.
  • 7I.eung VY, Gao B, Leung KK, el al. SOX9 governs differentia- tion stage-specific gene expression in growth plate chondrocytes via direct concomitant transactivation and repression [J]. PLoS Genet,2011,7(ll) :e1002356.
  • 8Martin JW, Zielenska M, Stein GS, et al. The role of RUNX2 in osteosarcoma oncogenesis[J ]. Sarcoma, 2011,2011 : 282745.
  • 9Chen NX, Duan D, O'Neill KD, et al. The mechanisms of uremic ser- um-induced expression of bone matrix proteins in bovine vascular smooth muscle cells[J]. Kidney Int,2006,70(6), 1046-1053.
  • 10Li X, Yang HY, Giachelli CM. Role of the sodium-dependent phosphate eolransporter, Pit-l, in vascular smooth muscle cell calcification[J]. Cite Res,2006,98(7) ,905-912.

同被引文献59

  • 1余毅,黄恬.硫代硫酸钠对高磷诱导的残肾大鼠血管钙化早期干预作用的观察[J].中国血液净化,2012,11(5):263-267. 被引量:4
  • 2Thanh-Mai Vo,Sinee Disthabanchong.Are there ways to attenuate arterial calcification and improve cardiovascular outcomes in chronic kidney disease?[J].World Journal of Cardiology,2014,6(5):216-226. 被引量:5
  • 3刘书馨,常明,刘红,王志宏,刘焱,藤兰波,赵华.血管平滑肌细胞凋亡与尿毒症血管钙化[J].中华肾脏病杂志,2007,23(6):362-365. 被引量:3
  • 4Mathew S, Lund R, Strebeck F, et al. Reversal of the adynamic bone disorder and decreased vascular calcification in chronic kidney disease by sevelamer carbonate therapy. J Am Soc Neph- ro1,2007,18 ( 1 ) : 122 - 130.
  • 5E1 - Abbadi MM, Pai AS, Leaf EM, et al. Phosphate feeding in- duces arterial medial calcification in uremic mice:role of serum phophorus, fibroblast groth factor- 23, and osteopontin. Kidney Int ,2009,75 ( 12 ) : 1297 - 1307.
  • 6Shanahan CM, Crouthamel MH, Kapustin A, et al. Arterial calci- fication in chronic kidney disease:key roles for calcium and phosphate. Circ Res,2011,109 (6) :697 - 711.
  • 7Hill KM, Martin BR, Wastney ME, et al. Oral calcium carbonate affects calcium but not phosphorus balance in stage 3 -4 chronic kidney disease. Kidney Int,2013,83 ( 5 ) : 959 - 966.
  • 8Block GA, Klassen PS, Lazarus JM, et al. Mineral metabolism, mortality,and morbidity in maintenance hemodialysis. J Am Soc Nephrol,2004,15 (8) :2208 - 2218.
  • 9Ciceri P, Elli F, Brenna I, et al. Lanthanum prevents high phos- phate - induced vascular calcification by preserving vascular smooth muscle lineage markers. Calcif Tissue Int, 2013,92 ( 6 ) : 521 - 530.
  • 10Burger D, Levin A. ' Sheding' light on mechanisms of hyper- phosphatemie vascular dysfunction. Kidney Int, 2013,83 ( 2 ) : 187 - 189.

引证文献3

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部